Position
XPONANCE LLC in Standard Biotools Inc.
Back to the book · All holders of LAB
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$8.51K$1.28 → $0.92
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 23.6K | $30.2K | — | — | — | 0.0% |
| Q1 2026 | 27K | $24.9K | $0.92 | −$8.51K | $3.17K | 0.0% |